335 related articles for article (PubMed ID: 25867463)
1. Clinical manifestations of patients with CASPR2 antibodies.
Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
[TBL] [Abstract][Full Text] [Related]
2. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies.
Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K
J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974
[TBL] [Abstract][Full Text] [Related]
3. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.
van Sonderen A; Schreurs MW; de Bruijn MA; Boukhrissi S; Nagtzaam MM; Hulsenboom ES; Enting RH; Thijs RD; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Neurology; 2016 May; 86(18):1692-9. PubMed ID: 27037230
[TBL] [Abstract][Full Text] [Related]
4. Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus.
Balint B; Regula JU; Jarius S; Wildemann B
J Neurol Sci; 2013 Apr; 327(1-2):73-4. PubMed ID: 23465509
[TBL] [Abstract][Full Text] [Related]
5. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
6. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
7. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
Syrbe S; Stettner GM; Bally J; Borggraefe I; Bien CI; Ferfoglia RI; Huppke P; Kern J; Polster T; Probst-Müller E; Schmid S; Steinfeld R; Strozzi S; Weichselbaum A; Weitz M; Ziegler A; Wandinger KP; Leypoldt F; Bien CG
Neurology; 2020 Jun; 94(22):e2290-e2301. PubMed ID: 32424051
[TBL] [Abstract][Full Text] [Related]
8. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome.
Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW
J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the clinical spectrum of CASPR2 antibody syndrome.
Boyko M; Au KLK; Casault C; de Robles P; Pfeffer G
J Neurol; 2020 Apr; 267(4):1137-1146. PubMed ID: 31912210
[TBL] [Abstract][Full Text] [Related]
10. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
Lang B; Makuch M; Moloney T; Dettmann I; Mindorf S; Probst C; Stoecker W; Buckley C; Newton CR; Leite MI; Maddison P; Komorowski L; Adcock J; Vincent A; Waters P; Irani SR
J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):353-361. PubMed ID: 28115470
[TBL] [Abstract][Full Text] [Related]
11. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis.
van Sonderen A; Petit-Pedrol M; Dalmau J; Titulaer MJ
Nat Rev Neurol; 2017 May; 13(5):290-301. PubMed ID: 28418022
[TBL] [Abstract][Full Text] [Related]
12. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes.
Irani SR; Vincent A
Handb Clin Neurol; 2016; 133():185-97. PubMed ID: 27112678
[TBL] [Abstract][Full Text] [Related]
14. Detection of LGI1 and CASPR2 antibodies with a commercial cell-based assay in patients with very high VGKC-complex antibody levels.
Yeo T; Chen Z; Chai JYH; Tan K
J Neurol Sci; 2017 Jul; 378():85-90. PubMed ID: 28566186
[TBL] [Abstract][Full Text] [Related]
15. Cramp-fasciculation syndrome in patients with and without neural autoantibodies.
Liewluck T; Klein CJ; Jones LK
Muscle Nerve; 2014 Mar; 49(3):351-6. PubMed ID: 23836298
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
17. VGKC complex antibodies in epilepsy: diagnostic yield and therapeutic implications.
Lilleker JB; Jones MS; Mohanraj R
Seizure; 2013 Nov; 22(9):776-9. PubMed ID: 23838087
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune epilepsy in children: case series and proposed guidelines for identification.
Suleiman J; Brilot F; Lang B; Vincent A; Dale RC
Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy and autoimmunity in pediatric patients.
Bektaş Ö; Jacobson L; Tutkak H; Karagöl S; Lang B; Clover L; Vincent A; Deda G
Neuropediatrics; 2015 Feb; 46(1):13-9. PubMed ID: 25290722
[TBL] [Abstract][Full Text] [Related]
20. Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2.
Michael S; Waters P; Irani SR
Pract Neurol; 2020 Oct; 20(5):377-384. PubMed ID: 32595134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
